{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Solution&page=6", "query": { "intervention": "Control Solution", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 3229, "total_pages": 323, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Solution&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Solution&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T18:17:53.256Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01275066", "title": "A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "MPS IV A" ], "interventions": [ { "name": "BMN 110 Weekly", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "BMN 110 Every Other Week", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioMarin Pharmaceutical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 177, "start_date": "2011-02", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2014-07-07", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 6, "location_summary": "Oakland, California • Wilmington, Delaware • Washington D.C., District of Columbia + 3 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01275066" }, { "nct_id": "NCT03846453", "title": "A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dry Eye" ], "interventions": [ { "name": "HL036 Ophthalmic Solution", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "HanAll BioPharma Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 637, "start_date": "2019-03-10", "completion_date": "2019-11-22", "has_results": true, "last_update_posted_date": "2022-04-14", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 12, "location_summary": "Phoenix, Arizona • Newport Beach, California • Torrance, California + 9 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Boynton Beach", "state": "Florida" }, { "city": "Coral Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03846453" }, { "nct_id": "NCT04456673", "title": "Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Dupilumab SAR231893", "type": "DRUG" }, { "name": "Inhaled Corticosteroid", "type": "DRUG" }, { "name": "Inhaled Long-Acting Beta Agonist", "type": "DRUG" }, { "name": "Inhaled Long-Acting Muscarinic Antagonist", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 935, "start_date": "2020-07-06", "completion_date": "2024-05-27", "has_results": true, "last_update_posted_date": "2025-05-29", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 92, "location_summary": "Cullman, Alabama • Jasper, Alabama • Scottsboro, Alabama + 79 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04456673" }, { "nct_id": "NCT05802173", "title": "Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia, Androgenetic" ], "interventions": [ { "name": "TDM-105795, 0.0025%", "type": "DRUG" }, { "name": "TDM-105795, 0.02%", "type": "DRUG" }, { "name": "TDM-105795 topical vehicle solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Technoderma Medicines Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 71, "start_date": "2023-03-06", "completion_date": "2024-01-29", "has_results": true, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 13, "location_summary": "North Little Rock, Arkansas • Rolling Meadows, Illinois • Plainfield, Indiana + 10 more", "locations": [ { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Rolling Meadows", "state": "Illinois" }, { "city": "Plainfield", "state": "Indiana" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05802173" }, { "nct_id": "NCT02257151", "title": "Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adult" ], "interventions": [ { "name": "BMS-986142", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 118, "start_date": "2014-09", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2015-09-24", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02257151" }, { "nct_id": "NCT06106009", "title": "A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "PF-07976016", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 117, "start_date": "2023-10-27", "completion_date": "2024-08-19", "has_results": false, "last_update_posted_date": "2024-09-23", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT06106009" }, { "nct_id": "NCT06011798", "title": "Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Macular Edema", "Retinal Disease", "Macular Edema", "Diabetes Mellitus", "Diabetic Retinopathy", "Retinal Degeneration", "Retinal Diseases", "Eye Diseases", "Edema" ], "interventions": [ { "name": "Aflibercept", "type": "DRUG" }, { "name": "foselutoclax", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Unity Biotechnology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 52, "start_date": "2023-08-23", "completion_date": "2025-04-08", "has_results": true, "last_update_posted_date": "2025-08-05", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 19, "location_summary": "Bakersfield, California • Beverly Hills, California • Huntington Beach, California + 16 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Longmont", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06011798" }, { "nct_id": "NCT00064402", "title": "Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Chronic Bronchitis", "Emphysema" ], "interventions": [ { "name": "arformoterol tartrate inhalation solution", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 741, "start_date": "2002-04", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 65, "location_summary": "Jasper, Alabama • Phoenix, Arizona • Tucson, Arizona + 59 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fair Oaks", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00064402" }, { "nct_id": "NCT04622345", "title": "Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Allergic Conjunctivitis" ], "interventions": [ { "name": "VSJ-110", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2020-11-21", "completion_date": "2021-06-28", "has_results": true, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 1, "location_summary": "Andover, Massachusetts", "locations": [ { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04622345" }, { "nct_id": "NCT01000311", "title": "A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Disease" ], "interventions": [ { "name": "MenACWY-CRM", "type": "BIOLOGICAL" }, { "name": "DTaP-IPV/Hib", "type": "BIOLOGICAL" }, { "name": "HBV", "type": "BIOLOGICAL" }, { "name": "PCV", "type": "BIOLOGICAL" }, { "name": "MMR", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "55 Days to 89 Days" }, "enrollment_count": 529, "start_date": "2009-11", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-10-22T18:17:53.256Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000311" } ] }